Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9771
Gene Symbol: RAPGEF5
RAPGEF5
0.010 Biomarker disease BEFREE The criteria for the diagnosis of NPHPT were as follows: serum PTH above the reference range (11-65 pg/mL), normal albumin-corrected serum calcium concentrations, normal 24-h urinary calcium excretion, serum 25OHD above 30 ng/mL, estimated GFR (MDRD) above 60 mL/min/1.73 m2 (with the exclusion of medications such as thiazide diuretics, lithium, bisphosphonates, and denosumab), a history of clinical symptoms of urolithiasis, and a family history of kidney stones. 31542783 2019
Entrez Id: 56302
Gene Symbol: TRPV5
TRPV5
0.010 GeneticVariation disease BEFREE Association of TRPV5 gene polymorphism with calcium urolithiasis: a case-control study from West Bengal, India. 31428848 2019
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.010 GeneticVariation disease BEFREE E-cadherin gene polymorphisms and susceptibility to urolithiasis in Iraqi children. 29055055 2019
Entrez Id: 799
Gene Symbol: CALCR
CALCR
0.010 GeneticVariation disease BEFREE There is insufficient data to fully confirm the association between CALCR rs1042138 and calcium stone urolithiasis susceptibility. 31626518 2019
Entrez Id: 7015
Gene Symbol: TERT
TERT
0.010 Biomarker disease BEFREE This included men aged 40-64 years with no prior history of urolithiasis who received continuous TRT for a diagnosis of hypogonadism between 2006 and 2014. 30903351 2019
Entrez Id: 2091
Gene Symbol: FBL
FBL
0.010 Biomarker disease BEFREE Therefore, this study aimed to investigate the prevalence of urolithiasis among NAFLD patients and determine whether the Fibrosis-4 (FIB-4) score, a surrogate marker of hepatic fibrosis, is associated with urolithiasis among NAFLD patients. 31471434 2019
Entrez Id: 3645
Gene Symbol: INSRR
INSRR
0.010 Biomarker disease BEFREE Using the Australian national heatwave definition with the EHF, emergency department presentations increased on heatwave days compared to non-heatwave days for total urinary disease (IRR 1.046, 95% CI 1.016-1.076), urolithiasis (IRR 1.106, 95% 1.046-1.169), and acute kidney injury (AKI) (IRR 1.416, 95% CI 1.258-1.594). 30687904 2019
Entrez Id: 51594
Gene Symbol: NBAS
NBAS
0.010 Biomarker disease BEFREE The results of this study suggest that none of the aforementioned urinary biomarkers (KIM-1, NAG and NGAL levels) may be useful for the early detection and/or follow-up of renal tubular injury and/or dysfunction in childhood urolithiasis. 28653226 2018
Entrez Id: 4669
Gene Symbol: NAGLU
NAGLU
0.010 Biomarker disease BEFREE The results of this study suggest that none of the aforementioned urinary biomarkers (KIM-1, NAG and NGAL levels) may be useful for the early detection and/or follow-up of renal tubular injury and/or dysfunction in childhood urolithiasis. 28653226 2018
Entrez Id: 221079
Gene Symbol: ARL5B
ARL5B
0.010 Biomarker disease BEFREE Arl5b was associated with the dynamic changes in the podocyte foot process in podocyte injury. miRNAs co-expressed with circRNAs, such as rno-miR-138-5p and rno-miR-672-5p, have been proven to be functional in hypercalciuria urolithiasis. 30200873 2018
Entrez Id: 65010
Gene Symbol: SLC26A6
SLC26A6
0.010 Biomarker disease BEFREE This study aimed to investigate the role of kidney SLC26A6 in urolithiasis. 30002986 2018
Entrez Id: 6332
Gene Symbol: SCN7A
SCN7A
0.010 Biomarker disease BEFREE The results of this study suggest that none of the aforementioned urinary biomarkers (KIM-1, NAG and NGAL levels) may be useful for the early detection and/or follow-up of renal tubular injury and/or dysfunction in childhood urolithiasis. 28653226 2018
Entrez Id: 3934
Gene Symbol: LCN2
LCN2
0.010 Biomarker disease BEFREE The results of this study suggest that none of the aforementioned urinary biomarkers (KIM-1, NAG and NGAL levels) may be useful for the early detection and/or follow-up of renal tubular injury and/or dysfunction in childhood urolithiasis. 28653226 2018
Entrez Id: 10724
Gene Symbol: OGA
OGA
0.010 Biomarker disease BEFREE To investigate relationships among urinary biomarkers [kidney injury molecule-1 (KIM-1), N-acetyl-β-glucosaminidase (NAG)], neutrophil gelatinase-associated lipocalin (NGAL) levels and renal tubular injury in childhood urolithiasis. 28653226 2018
Entrez Id: 26762
Gene Symbol: HAVCR1
HAVCR1
0.010 Biomarker disease BEFREE The results of this study suggest that none of the aforementioned urinary biomarkers (KIM-1, NAG and NGAL levels) may be useful for the early detection and/or follow-up of renal tubular injury and/or dysfunction in childhood urolithiasis. 28653226 2018
Entrez Id: 4025
Gene Symbol: LPO
LPO
0.010 AlteredExpression disease BEFREE SK exhibited antilithiatic and diuretic potential in ethylene glycol and sodium oxalate induced urolithiasis in ratsElevated urinary stone markers (Calcium, oxalate, uric acid, magnesium and phosphates) in plasma and renal tubular enzymes (LDH, GGT, ALP, AST ALT) in urolithiatic rats were reversed by SK treatmentSK administration significantly reduced the level of renal stress markers like Urea, Creatinine, LPO and elevated SOD, GPx, GSH levels aiding in nephroprotectionSK also provides structural and functional protection against ethylene glycol- induced renal calculus in rats as evidenced by histopathological studies. 28808392 2017
Entrez Id: 653590
Gene Symbol: GGTLC5P
GGTLC5P
0.010 AlteredExpression disease BEFREE SK exhibited antilithiatic and diuretic potential in ethylene glycol and sodium oxalate induced urolithiasis in ratsElevated urinary stone markers (Calcium, oxalate, uric acid, magnesium and phosphates) in plasma and renal tubular enzymes (LDH, GGT, ALP, AST ALT) in urolithiatic rats were reversed by SK treatmentSK administration significantly reduced the level of renal stress markers like Urea, Creatinine, LPO and elevated SOD, GPx, GSH levels aiding in nephroprotectionSK also provides structural and functional protection against ethylene glycol- induced renal calculus in rats as evidenced by histopathological studies. 28808392 2017
Entrez Id: 10850
Gene Symbol: CCL27
CCL27
0.010 Biomarker disease BEFREE SK exhibited antilithiatic and diuretic potential in ethylene glycol and sodium oxalate induced urolithiasis in ratsElevated urinary stone markers (Calcium, oxalate, uric acid, magnesium and phosphates) in plasma and renal tubular enzymes (LDH, GGT, ALP, AST ALT) in urolithiatic rats were reversed by SK treatmentSK administration significantly reduced the level of renal stress markers like Urea, Creatinine, LPO and elevated SOD, GPx, GSH levels aiding in nephroprotectionSK also provides structural and functional protection against ethylene glycol- induced renal calculus in rats as evidenced by histopathological studies. 28808392 2017
Entrez Id: 6569
Gene Symbol: SLC34A1
SLC34A1
0.010 Biomarker disease BEFREE Genome-wide association studies have shown that CLDN14 and NPT2 are associated with urolithiasis in Caucasian and Japanese populations, respectively. 27539983 2017
Entrez Id: 6590
Gene Symbol: SLPI
SLPI
0.010 Biomarker disease BEFREE SK exhibited antilithiatic and diuretic potential in ethylene glycol and sodium oxalate induced urolithiasis in ratsElevated urinary stone markers (Calcium, oxalate, uric acid, magnesium and phosphates) in plasma and renal tubular enzymes (LDH, GGT, ALP, AST ALT) in urolithiatic rats were reversed by SK treatmentSK administration significantly reduced the level of renal stress markers like Urea, Creatinine, LPO and elevated SOD, GPx, GSH levels aiding in nephroprotectionSK also provides structural and functional protection against ethylene glycol- induced renal calculus in rats as evidenced by histopathological studies. 28808392 2017
Entrez Id: 6647
Gene Symbol: SOD1
SOD1
0.010 AlteredExpression disease BEFREE SK exhibited antilithiatic and diuretic potential in ethylene glycol and sodium oxalate induced urolithiasis in ratsElevated urinary stone markers (Calcium, oxalate, uric acid, magnesium and phosphates) in plasma and renal tubular enzymes (LDH, GGT, ALP, AST ALT) in urolithiatic rats were reversed by SK treatmentSK administration significantly reduced the level of renal stress markers like Urea, Creatinine, LPO and elevated SOD, GPx, GSH levels aiding in nephroprotectionSK also provides structural and functional protection against ethylene glycol- induced renal calculus in rats as evidenced by histopathological studies. 28808392 2017
Entrez Id: 27295
Gene Symbol: PDLIM3
PDLIM3
0.010 Biomarker disease BEFREE SK exhibited antilithiatic and diuretic potential in ethylene glycol and sodium oxalate induced urolithiasis in ratsElevated urinary stone markers (Calcium, oxalate, uric acid, magnesium and phosphates) in plasma and renal tubular enzymes (LDH, GGT, ALP, AST ALT) in urolithiatic rats were reversed by SK treatmentSK administration significantly reduced the level of renal stress markers like Urea, Creatinine, LPO and elevated SOD, GPx, GSH levels aiding in nephroprotectionSK also provides structural and functional protection against ethylene glycol- induced renal calculus in rats as evidenced by histopathological studies. 28808392 2017
Entrez Id: 26033
Gene Symbol: ATRNL1
ATRNL1
0.010 Biomarker disease BEFREE SK exhibited antilithiatic and diuretic potential in ethylene glycol and sodium oxalate induced urolithiasis in ratsElevated urinary stone markers (Calcium, oxalate, uric acid, magnesium and phosphates) in plasma and renal tubular enzymes (LDH, GGT, ALP, AST ALT) in urolithiatic rats were reversed by SK treatmentSK administration significantly reduced the level of renal stress markers like Urea, Creatinine, LPO and elevated SOD, GPx, GSH levels aiding in nephroprotectionSK also provides structural and functional protection against ethylene glycol- induced renal calculus in rats as evidenced by histopathological studies. 28808392 2017
Entrez Id: 1476
Gene Symbol: CSTB
CSTB
0.010 Biomarker disease BEFREE Of the four studies with ULD CT for both males and females, the prevalence of urolithiasis ranged from 36% and 73%, with additional pathologies found in 12-15%. 27810168 2017
Entrez Id: 728226
Gene Symbol: GGTLC3
GGTLC3
0.010 AlteredExpression disease BEFREE SK exhibited antilithiatic and diuretic potential in ethylene glycol and sodium oxalate induced urolithiasis in ratsElevated urinary stone markers (Calcium, oxalate, uric acid, magnesium and phosphates) in plasma and renal tubular enzymes (LDH, GGT, ALP, AST ALT) in urolithiatic rats were reversed by SK treatmentSK administration significantly reduced the level of renal stress markers like Urea, Creatinine, LPO and elevated SOD, GPx, GSH levels aiding in nephroprotectionSK also provides structural and functional protection against ethylene glycol- induced renal calculus in rats as evidenced by histopathological studies. 28808392 2017